To date, there is accumulating evidence that PPM1D is involved in multiple human tumors, including neuroblastoma, pancreatic adenocarcinoma, medulloblastoma, breast cancer, ovarian cancer and hepatocellular carcinoma, and is a promising therapeutic target[29]. This evidence concerns the gene PPM1D and ovarian carcinoma.